Revolution Medicines Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Revolution Medicines Inc had 440.94M in cash and cash equivalents.

Revolution Medicines Inc reported 723.21M in total liabilities as of the latest reported quarter, including 290.42M in current liabilities and 432.79M in non-current liabilities.

As of the latest reported quarter, Revolution Medicines Inc's total assets were 2.35B, consisting of 2.08B in current assets and 279.47M in non-current assets.

Revolution Medicines Inc reported 1.63B in total shareholders' equity as of the latest reported quarter.